MANNKIND CORP Accumulated Other Comprehensive Income
MANNKIND CORP (MNKD) had Accumulated Other Comprehensive Income of -$19.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-05
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$19.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$4.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $115.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $137.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$19.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | -$4.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $115.00K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $137.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.26M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $1.17M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.11M 10-K · filed 2026-02-26 |
| 2024-09-30 | $588.00K 10-Q · filed 2024-11-07 |
| 2023-09-30 | $443.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $443.00K 10-Q · filed 2023-08-07 |
| 2022-09-30 | -$1.21M 10-Q · filed 2022-11-08 |
| 2022-06-30 | -$1.21M 10-Q · filed 2022-08-09 |
| 2022-03-31 | -$1.08M 10-Q · filed 2022-05-05 |
| 2019-12-31 | -$19.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | -$20.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$19.00K 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$19.00K 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$19.00K 10-K · filed 2020-02-25 |
| 2018-09-30 | -$18.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | -$18.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | -$15.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$18.00K 10-K · filed 2019-02-26 |
| 2017-09-30 | -$20.00K 10-Q · filed 2017-11-07 |
| 2017-06-30 | -$21.00K 10-Q · filed 2017-08-07 |
| 2017-03-31 | -$24.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | -$24.00K 10-K · filed 2018-02-27 |
| 2016-09-30 | -$21.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | -$21.00K 10-Q/A · filed 2016-08-10 |
| 2016-03-31 | -$19.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | -$20.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | -$19.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | -$20.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | -$21.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | -$14.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | -$11.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | -$4.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | -$4.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | -$4.00K 10-K · filed 2015-03-02 |
| 2013-09-30 | -$9.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | -$8.00K 10-Q · filed 2013-08-09 |
| 2013-03-31 | -$8.00K 10-Q · filed 2013-05-10 |
| 2012-12-31 | -$6.00K 10-K · filed 2014-03-03 |
| 2012-09-30 | -$8.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | -$9.00K 10-Q · filed 2012-08-09 |
| 2012-03-31 | -$3.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $44.00K 10-K · filed 2013-03-18 |
| 2011-09-30 | $45.00K 10-Q · filed 2011-11-04 |
| 2011-06-30 | $38.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | $74.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |